SMS Pharmaceuticals Limited (BOM:532815)
India · Delayed Price · Currency is INR 388.75
-2.70 (-0.69%)
At close: Apr 2, 2026
SMS Pharmaceuticals Employees
SMS Pharmaceuticals had 1,470 employees as of March 31, 2025. The number of employees increased by 273 or 22.81% compared to the previous year.
Employees
1,470
Change (1Y)
273
Growth (1Y)
22.81%
Revenue / Employee
6.10M INR
Profits / Employee
609.46K INR
Market Cap
36.36B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 1,470 | 273 | 22.81% |
| Mar 31, 2024 | 1,197 | 102 | 9.32% |
| Mar 31, 2023 | 1,095 | 64 | 6.21% |
| Mar 31, 2022 | 1,031 | -49 | -4.54% |
| Mar 31, 2021 | 1,080 | -276 | -20.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IOL Chemicals and Pharmaceuticals | 2,891 |
| Neuland Laboratories | 1,794 |
| Shilpa Medicare | 998 |
| Bajaj HealthCare | 918 |
| NGL Fine-Chem | 520 |
| Gujarat Themis Biosyn | 221 |
| Influx Healthtech | 163 |
| Shree Ganesh Remedies | 149 |
SMS Pharmaceuticals News
- 4 months ago - SMS Pharmaceuticals successfully concludes USFDA inspection at Vizag API facility - Business Upturn
- 4 months ago - SMS Pharmaceuticals shares jump 4% as VKT Pharma secures US FDA approval for reformulated Ranitidine - Business Upturn
- 4 months ago - SMS Pharmaceuticals’ VKT Pharma receives US FDA approval for reformulated Ranitidine - Business Upturn
- 5 months ago - SMS Pharmaceuticals Ltd (BOM:532815) Q2 2026 Earnings Call Highlights: Record Profit Growth and ... - GuruFocus
- 5 months ago - Q2 2026 SMS Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 7 months ago - SMS Pharma shares surge over 7% after USFDA grants EIR for Hyderabad facility - Business Upturn
- 8 months ago - SMS Pharmaceuticals Q1 Results: Revenue jumps 19% YoY to Rs 196.05 crore, Net profit up14% YoY - Business Upturn
- 10 months ago - SMS Pharmaceuticals share jump 6% after its Hyderabad facility clears USFDA inspection with zero observations - Business Upturn